Korean J Hepatobiliary Pancreat Surg.  2001 Jul;5(1):169-173.

Clinical Efficacy and Safety of Intravenous levofloxacin in Patients of Abdominal Operati

Affiliations
  • 1Department of Surgery, College of Medicine, Yonsei University, Korea. wjlee@yumc.yonsei.ac.kr

Abstract

BACKGROUND/AIMS: For the investigation of the efficacy and safety of intravenous levofloxacin, The clinical study was carrried out in 30 patients with abdominal operation, especially in hepatobiliary and pancreatic division.
METHODS
Randomly chosen patients received intravenous levofloxacin (250mg bid) for only 7 days. Clinical and microbiological evaluation were conducted on the day of starting and finishing levofloxacin treatmeat except for the case of combined use of antibiotics.
RESULTS
The most commonly isolated organism was staphylococcus aureus(33%, 3/9). The overall bacteriologic eradication rate was 67%, (6/9) with clinical success rate was 96%(29/30), There were no significant dverse effects to stop the administration of the drug.
CONCLUSION
These results suggest that intravenous levofloxacin is effective and safe antibiotics in the fields management of abdominal operation especially in hepatobiliary and pancreas surgery.

Keyword

Levofloxacin; Quinolone antibiotics

MeSH Terms

Anti-Bacterial Agents
Humans
Levofloxacin*
Pancreas
Staphylococcus
Anti-Bacterial Agents
Full Text Links
  • KJHBPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr